ANTI-ANGIOGENIC THERAPY IN PATIENTS WITH PATHOLOGIC MYOPIA AND CHOROIDAL NEOVASCULARIZATION

Purpose of the study: to study the efficacy and safety of Ranibizumab in patients with pathologic myopia and choroidal neovascularization (CNV). 22 patients (22 eyes) with myopic CNV were included in the study. Mean age was 54.0 ± 14.4 years, axial length -28.25± 1.9 mm,follow-up-from 12 to 59 month...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: S. A. Korotkikh, E. V. Bobykin, G. V. Zhiborkin, A. Y. Anashkin, A. V. Berezin
Format: article
Langue:RU
Publié: Scientific Сentre for Family Health and Human Reproduction Problems 2016
Sujets:
Q
Accès en ligne:https://doaj.org/article/113add6fa8974e6a8fda12e9e7207145
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!